NABL, CAP, ISO
Overview of CA125
What is CA125?
This test is used to monitor treatment for ovarian cancer or to detect recurrence; sometimes to evaluate a pelvic mass and it can also be ordered to help detect early ovarian cancer in those identified as being at high risk.
The sample type collected for CA125 is: Blood
Preparation for CA125
- No special preparation required
Why Get Tested for CA125?
- If you have a pelvic mass and the doctor is suspecting ovarian cancer
- When you start treatment for ovarian cancer to monitor further therapy or detect recurrence
- Along with a transvaginal oltrasound, it may be ordered to monitor women who have a high risk for ovarian cancer but have no disease as yet
What Results of CA125 mean?
- When used during ovarian cancer therapy, if the level of CA 125 falls during therapy, it generally indicates that the cancer is responding to treatment. If it rises or stays the same, the cancer may not be responding. High CA 125 after completion of treatment may indicate that the cancer has come back
- In a women with a pelvic mass and in a women with high risk of developing ovarian cancer, a significantly elevated CA 125 is a concern but does not necessarily indicate ovarian cancer and should be confirmed by other tests
Diagno Labs, established in the year 2012, is uniquely positioned to more effectively support local pathology for enhanced patient care. Diagno Labs, with complementary areas of expertise and service offerings, allows us to build on the company's leadership positions, provide access to medical and scientific expertise, expand geographical presence to better serve customers and emerge as the most valued company in the healthcare industry. Our Parent group RJ Corp is a well-diversified Indian MNC,with an annual turnover of over 15 billion rupees. Established in the 1990s, RJ Corp has achieved heights of success under the dynamic leadership and guidance of its founder-chairman Mr. Ravi Kant Jaipuria. The group has diversified business interests in beverages, breweries, real estate, hospitality, healthcare, education, dairy, food service and retail. Our network company, Cryobanks International India, is a leader in the collection, processing and banking of umbilical cord blood stem cells.